Ing Groep Nv Abb Vie Inc. Transaction History

Ing Groep Nv

$16.5 Billion
Q3 2024

A detailed history of Ing Groep Nv transactions in Abb Vie Inc. stock. As of the latest transaction made, Ing Groep Nv holds 334,778 shares of ABBV stock, worth $56.2 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

334,778

Previous 431,346 22.39%

Holding current value

$56.2 Million

Previous $74 Million 10.64%

% of portfolio

0.4%

Previous 0.45%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$163.84 - $199.33 $15.8 Million - $19.2 Million	-96,568 Reduced 22.39%	334,778 $66.1 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $667,454 - $779,437	-4,312 Reduced 0.99%	431,346 $74 Million
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $27.4 Million - $31.2 Million	171,224 Added 64.75%	435,658 $79.3 Million
Q4 2023 Feb 08, 2024	SELL	$137.6 - $154.97 $5.4 Million - $6.08 Million	-39,234 Reduced 12.92%	264,434 $41 Million
Q3 2023 Oct 27, 2023	SELL	$133.59 - $154.65 $15 Million - $17.4 Million	-112,553 Reduced 27.04%	303,668 $45.3 Million
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $29.8 Million - $37.1 Million	-225,021 Reduced 35.09%	416,221 $56.1 Million
Q1 2023 May 09, 2023	BUY	$144.61 - $166.54 $33.9 Million - $39.1 Million	234,509 Added 57.66%	641,242 $102 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $5.34 Million - $6.4 Million	-38,610 Reduced 8.67%	406,733 $65.8 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $6.59 Million - $7.56 Million	49,083 Added 12.39%	445,343 $59.8 Million
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $15.9 Million - $20.3 Million	115,813 Added 41.3%	396,260 $60.7 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $6.67 Million - $8.27 Million	50,510 Added 21.97%	280,447 $45.5 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $698,939 - $884,360	6,506 Added 2.91%	229,937 $31.1 Million
Q3 2021 Nov 02, 2021	BUY	$106.4 - $120.78 $8.33 Million - $9.46 Million	78,301 Added 53.95%	223,431 $24.1 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $2.93 Million - $3.27 Million	27,866 Added 23.76%	145,130 $16.3 Million
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $63,323 - $69,711	-619 Reduced 0.53%	117,264 $12.7 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $6.22 Million - $8.4 Million	77,319 Added 190.61%	117,883 $12.6 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $2.07 Million - $2.44 Million	24,153 Added 147.18%	40,564 $3.55 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $641,620 - $858,584	8,745 Added 114.08%	16,411 $1.61 Million
Q1 2020 May 06, 2020	SELL	$64.5 - $97.79 $878,167 - $1.33 Million	-13,615 Reduced 63.98%	7,666 $584,000
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $5.18 Million - $6.48 Million	-71,836 Reduced 77.15%	21,281 $1.88 Million
Q3 2019 Nov 08, 2019	SELL	$62.98 - $75.72 $8.11 Million - $9.76 Million	-128,835 Reduced 58.05%	93,117 $7.05 Million
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $321,470 - $410,914	-4,893 Reduced 2.16%	221,952 $16.1 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $14.2 Million - $16.7 Million	183,863 Added 427.77%	226,845 $18.3 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $505,246 - $623,104	-6,490 Reduced 13.12%	42,982 $3.96 Million
Q3 2018 Nov 06, 2018	BUY	$88.91 - $98.84 $4.4 Million - $4.89 Million	49,472 New	49,472 $4.68 Million
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $31.5 Million - $37.3 Million	-351,320 Closed	0 $0
Q1 2018 May 07, 2018	BUY	$92.01 - $123.21 $29.4 Million - $39.3 Million	319,305 Added 997.36%	351,320 $33.3 Million
Q4 2017 Feb 06, 2018	SELL	$89.56 - $98.21 $3.02 Million - $3.31 Million	-33,679 Reduced 51.27%	32,015 $3.1 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $4.59 Million - $5.86 Million	65,694	65,694 $5.84 Million

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.

Account